Google
×
Agenus is an immuno-oncology company focused on the discovery and development of potentially revolutionary new treatments that leverage the body's immune ...
To participate in monthly shareholder calls hosted by Agenus on Wednesdays at 4 p.m. ET, please register by emailing investor@agenusbio.com ...
Agenus Inc. Common Stock is estimated to report earnings on 05/14/2024. The upcoming earnings date is derived from an algorithm based on a company's ...
People also ask
Head of Investor Relations, N/A, N/A, N/A. Ms. Tracy Mazza Clemente, Chief People Officer, N/A, N/A, N/A. Mr. Dhan Chand, Scientific Director & Head of Drug ...
The Investor Relations website contains information about Aceragen, Inc.'s business for stockholders, potential investors, and financial analysts.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Mar 14, 2024 · Please go ahead. Zack Armen -- Head of Investor Relations. Thank you, Audra, and thank you all for joining us today. Today's call is being ...
We are a leader in integrated residential real estate services, combining the world's most extensive agent network, industry-leading brands, integrated ...
Rating (2,975)
Agenus (AGEN) will release its next earnings report on May 8, 2024. In the ... investors and does not represent returns that any investor actually attained.
CyberAgent's investor relations contents, include the competitive advantage of each business and the IR channel, to aim to be a company supported in the mid ...